TSE:PRN Profound Medical - PRN Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. C$12.64 +0.45 (+3.69%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's RangeC$12.01▼C$12.6450-Day RangeC$12.19▼C$18.0052-Week RangeC$4.21▼C$18.33Volume3,200 shsAverage Volume22,125 shsMarket CapitalizationC$264.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsHeadlinesOptions ChainSocial Media About Profound Medical (TSE:PRN) StockProfound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.Read More Receive PRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address PRN Stock News HeadlinesMarch 23, 2023 | americanbankingnews.comProfound Medical Corp. Expected to Post Q1 2023 Earnings of ($0.36) Per Share (TSE:PRN)October 15, 2022 | marketwatch.comProfound Medical to Release Third Quarter 2022 Financial Results on November 3 - Conference Call to FollowMarch 26, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. October 13, 2022 | finance.yahoo.comProfound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to FollowSeptember 4, 2022 | marketwatch.comProfound Medical Provides TULSA-PRO(R) Reimbursement UpdateAugust 30, 2022 | nz.finance.yahoo.comWe're Hopeful That Profound Medical (TSE:PRN) Will Use Its Cash WiselyAugust 4, 2022 | finance.yahoo.comProfound Medical Announces Second Quarter 2022 Financial ResultsJune 16, 2022 | finance.yahoo.comProfound Medical to Participate in the Cowen 7th Annual FutureHealth ConferenceMarch 26, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. May 18, 2022 | finance.yahoo.comProfound Medical Clarifies Recent Insider BuyingMarch 4, 2022 | finance.yahoo.comCompanies Like Profound Medical (TSE:PRN) Are In A Position To Invest In GrowthJanuary 18, 2022 | finance.yahoo.comBullish Profound Medical Corp. (TSE:PRN) insiders filled their treasuries with US$782k worth of stock over last yearOctober 28, 2021 | finance.yahoo.comWill Profound Medical (PROF) Report Negative Earnings Next Week? What You Should KnowOctober 4, 2021 | finance.yahoo.comProfound Medical (TSE:PRN) shareholders have earned a 41% CAGR over the last three yearsSeptember 8, 2021 | finance.yahoo.comProfound Medical to Participate in September Virtual Investor ConferencesJuly 28, 2021 | finance.yahoo.comPROFOUND MEDICL (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseApril 14, 2021 | finance.yahoo.comProfound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor ConferenceMarch 1, 2021 | msn.comVictorian mental health royal commission final report finds system operates in crisis modeFebruary 28, 2021 | msn.comNotre Dame nation mourns the death of former football star Louis Nix IIIFebruary 24, 2021 | nytimes.comOn the Front Lines of Diplomacy, but at the Back of the Vaccine QueueFebruary 22, 2021 | msn.comRobert Jorvig, first Metropolitan Council head, dies at 99February 21, 2021 | wsj.com‘Mr. Humble and Dr. Butcher’ Review: A Heart in the Right PlaceFebruary 18, 2021 | msn.comFull Transcript: San Diego State of the County Address 2021January 30, 2021 | marketwatch.comGlobal Medical Pressure Transducers Market 2020 Manufacturer Analysis, Technology Advancements, Industry Scope and Forecast to 2025January 20, 2021 | marketwatch.comMedical Mobility Aid Device Market Research Report Includes Size, Capacity, Production, Revenue, Gross Margin, Forecast to 2026January 8, 2021 | marketwatch.comMedical Software Market Size is Estimated to Accelerate at CAGR of 6.63% Industry Segmentation by Companies, Types and Application 2021 to 2025January 1, 2021 | finance.yahoo.comA Look At The Fair Value Of Profound Medical Corp. (TSE:PRN)See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive PRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address PRN Company Calendar Today3/26/2023Next Earnings (Estimated)5/08/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolTSE:PRN CUSIPN/A CIKN/A Webwww.profoundmedical.com Phone647-476-1350FaxN/AEmployees146Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($1.75) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-28,670,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-43.23% Return on Assets-24.47% Debt Debt-to-Equity Ratio15.83 Current Ratio14.82 Quick Ratio14.98 Sales & Book Value Annual SalesC$6.68 million Price / Sales39.57 Cash FlowC$3.89 per share Price / Cash Flow3.25 Book ValueC$2.49 per share Price / Book5.08Miscellaneous Outstanding Shares20,910,000Free FloatN/AMarket CapC$264.30 million OptionableOptionable Beta1.23 Key ExecutivesDr. Arun Swarup Menawat MBA (Age 68)Ph.D., Chairman & CEO Comp: $3.08MMr. Rashed Dewan (Age 55)Chief Financial Officer Comp: $198.13kDr. Mathieu Burtnyk (Age 41)Sr. VP of Product Leader TULSA-PRO Comp: $221.27kMr. Stephen KilmerInvestor RelationsMr. Hartmut WarnkenChief Commercial Officer of OUSMr. Jacques F. Cornet (Age 67)Sr. VP & Product Leader Sonalleve Mr. Abbey GoodmanChief Commercial Officer of USMr. Matthew Sobczyk C.A.CPA, Assistant Corp. ControllerMr. Levant TinazSoftware DeveloperMore ExecutivesKey CompetitorsAkuminTSE:AKUSernovaCVE:SVASupreme CannabisTSE:FIREVIVO CannabisCVE:ABCNDialogue Health TechnologiesTSE:CAREView All Competitors PRN Stock - Frequently Asked Questions How have PRN shares performed in 2023? Profound Medical's stock was trading at C$14.48 at the beginning of 2023. Since then, PRN shares have decreased by 12.7% and is now trading at C$12.64. View the best growth stocks for 2023 here. When is Profound Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023. View our PRN earnings forecast. What other stocks do shareholders of Profound Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Profound Medical investors own include Orocobre (ORL), Ballard Power Systems (BLDP), Whitecap Resources (WCP), Alcanna (CLIQ), Just Energy Group (JE), Kezar Life Sciences (KZR), Lithium Americas (LAC), Russel Metals (RUS) and Absolute Software Co. (ABT.TO) (ABT). What is Profound Medical's stock symbol? Profound Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "PRN." How do I buy shares of Profound Medical? Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Profound Medical's stock price today? One share of PRN stock can currently be purchased for approximately C$12.64. How much money does Profound Medical make? Profound Medical (TSE:PRN) has a market capitalization of C$264.30 million and generates C$6.68 million in revenue each year. The company earns C$-28,670,000.00 in net income (profit) each year or C($1.75) on an earnings per share basis. How many employees does Profound Medical have? The company employs 146 workers across the globe. How can I contact Profound Medical? The official website for the company is www.profoundmedical.com. The company can be reached via phone at 647-476-1350. This page (TSE:PRN) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.